Viewing Study NCT01521767


Ignite Creation Date: 2025-12-25 @ 12:37 AM
Ignite Modification Date: 2026-02-25 @ 6:35 PM
Study NCT ID: NCT01521767
Status: COMPLETED
Last Update Posted: 2021-01-27
First Post: 2012-01-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pharmacokinetics and Relative Bioavailability Study
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module